Assessment of prognostic value of "neutrophil to lymphocyte ratio" and "prognostic nutritional index" as a sytemic inflammatory marker in non-small cell lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 9, 2015, Pages 3997-4002

  Kos, Fahriye Tugba ^a   Hocazade, Cemil ^b   Kos, Mehmet ^a   Uncu, Dogan ^b   Karakas, Esra ^b   Dogan, Mutlu ^b   Uncu, Hikmet Gulsen ^c   Ozdemir, Nuriye ^b   Zengin, Nurullah ^b  

^a DUZCE UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Turkish Drug and Medical Device Institution   (Turkey)

Author keywords

Lung cancer; Lymphocyte; Neutrophil; Prognosis; Prognostic nutritional index

Indexed keywords

BIOLOGICAL MARKER;

ADENOCARCINOMA; ADULT; AGED; CANCER STAGING; COMPLICATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LUNG TUMOR; LYMPH NODE METASTASIS; LYMPHOCYTE; MALE; MIDDLE AGED; MORTALITY; NEUTROPHIL; NON SMALL CELL LUNG CANCER; NUTRITIONAL STATUS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHILS; NUTRITIONAL STATUS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84930165655     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.9.3997     Document Type: Article

References (28)

1. Balkwill F, Mantovani A (2001). Inflammation and cancer: back to virchow? Lancet, 357, 539-45.
2. Bremnes RM, Al-Shibli K, Donnem T, et al (2011). The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression and prognosis: emphasis on non-small cell lung cancer. J Thorac Oncol, 6, 824-33.
3. Cedrés S, Torrejon D, Martínez A, et al (2012). Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol, 14, 864-9.
4. Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7.
5. Crinò L, Weder W, van Meerbeeck J, Felip E (2010). ESMO Guidelines Working Group: Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 103-15.
6. Feng JF, Chen QX (2014). Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma. Ther Clin Risk Manag, 10, 1-7.
7. Kacan T, Babacan NA, Seker M, et al (2014). Could the neutrophil to lymphocyte ratio be a poor prognostic factor for non small cell lung cancers? Asian Pac J Cancer Prev, 15, 2089-94.
8. Kaya V, Yildirim M, Demirpence O, Yildiz M, Yalcin A (2013). Prognostic significance of basic laboratory methods in non- small-cell-lung cancer. Asian PacJ Cancer Prev, 14, 5473-6.
9. Kinoshita A, Onoda H, Imai N, et al (2012). Comparison of the prognostic volue of inflammation-based prognostic scores in patients with hepatocellularcarcinoma. Br J Cancer, 107, 988-93.
10. Kwon HC, Kim SH, Oh SY, et al (2012). Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers, 17, 216-22.
11. Li QQ, Lu ZH, Yang L, et al (2014). Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev, 15, 945-50.
12. Migita K, Takayama T, Saeki K,et al (2013). The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumorstage. Ann Surg Oncol, 20, 2647-54.
13. Mohri Y, Inoue Y, Tanaka K, et al (2013). Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg, 37, 2688-92.
14. Nozoe T, Kimura Y, Ishida M, et al (2002). Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol, 28, 396-400.
15. O'callaghan Ds, O'donnell D, O'connell F, O'byrne Kj (2010). The role of inflammation in the pathogenesis of non-small cell lung cancer. J Thorac Oncol, 5, 2024-36.
16. Onodera T, Goseki N, Kosaki G (1984). Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi, 85, 1001-5.
17. Pinato DJ, North BV, Sharma R (2012). A novel, externally validated inflammation based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer, 106, 1439-45.
18. Pinato DJ, Shiner RJ, Seckl MJ, et al (2014). Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer, 110, 1930-35.
19. Sarraf KM, Belcher E, Raevsky E, et al (2009). Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg, 137, 425-8.
20. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
21. Sun K, Chen S, Xu J, Li G, He Y (2014). The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol, 14, 1537-49
22. Tomita M, Shimizu T, Ayabe T, Yonei A, Onitsuka T (2011). Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after cerative resection for non-small celllung cancer. Anticancer Res, 31, 2995-8.
23. Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42.
24. Wang DS, Luo HY, Qiu MZ, et al (2012). Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol, 29, 3092-100.
25. Xu AM, Huang L, Zhu L, Wei ZJ (2014). Significance of peripheral neutrophil-lymphocyte ratio among gastric cancer patients and construction of a treatment-predictive model: a study based on 1131 cases. Am J Cancer Res, 4, 189-95.
26. Yao Y, Yuan D, Liu H, Gu X, Song Y (2013). Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunol Immunother, 62, 471-9.
27. Yao ZH, Tian GY, Wan YY, et al (2013). Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. J Cancer Res Clin Oncol, 139, 2117-23.
28. Yildirim M, Yildiz M, Duman E, Goktas S, Kaya V (2013). Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer. J Buon, 18, 728-32.